{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(3)"],"submitter":["Shrestha DB"],"pubmed_abstract":["Cardiac pacing has undergone a significant transformation in the last decade. Leadless pacing (LP), once only a conceptual idea stemming from the early interest in eliminating lead-related complications of transvenous pacemakers, has now become a reality in clinical practice. Since the introduction of the first human single-chamber asynchronous leadless ventricular pacing in 2012, atrioventricular-synchronized single- or dual-chamber leadless pacing systems have been approved for clinical use since 2020. Leadless cardiac resynchronization therapy (CRT) has shown optimistic results in case series and awaits its full utility in real-world clinical practice. With the successful feasibility study of leadless conduction system pacing, we are eagerly awaiting long-term safety and efficacy data o"],"journal":["Journal of clinical medicine"],"pagination":["1251"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12897699"],"repository":["biostudies-literature"],"pubmed_title":["Era of Synchronized Physiologic Leadless Pacing: A Novel Approach to Cardiac Pacing and Ongoing Development."],"pmcid":["PMC12897699"],"pubmed_authors":["Shtembari J","Garg A","Pillai A","Storey J","Chaudhary A","Shrestha DB","Katz DH"],"additional_accession":[]},"is_claimable":false,"name":"Era of Synchronized Physiologic Leadless Pacing: A Novel Approach to Cardiac Pacing and Ongoing Development.","description":"Cardiac pacing has undergone a significant transformation in the last decade. Leadless pacing (LP), once only a conceptual idea stemming from the early interest in eliminating lead-related complications of transvenous pacemakers, has now become a reality in clinical practice. Since the introduction of the first human single-chamber asynchronous leadless ventricular pacing in 2012, atrioventricular-synchronized single- or dual-chamber leadless pacing systems have been approved for clinical use since 2020. Leadless cardiac resynchronization therapy (CRT) has shown optimistic results in case series and awaits its full utility in real-world clinical practice. With the successful feasibility study of leadless conduction system pacing, we are eagerly awaiting long-term safety and efficacy data o","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Feb","modification":"2026-07-07T03:13:01.904Z","creation":"2026-07-07T03:09:45.331Z"},"accession":"S-EPMC12897699","cross_references":{"pubmed":["41682932"],"doi":["10.3390/jcm15031251"]}}